Filing Details

Accession Number:
0001209191-19-057821
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-22 16:59:40
Reporting Period:
2019-11-20
Accepted Time:
2019-11-22 16:59:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
718937 Staar Surgical Co STAA Ophthalmic Goods (3851) 953797439
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1781933 C. Graydon Hansen 25651 Atlantic Ocean Drive
Lake Forest CA 92630
Sr. Vp, Global Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-11-20 17,083 $35.02 8,334 No 4 S Direct
Common Stock Acquisiton 2019-11-22 9,076 $9.30 17,410 No 4 M Direct
Common Stock Acquisiton 2019-11-22 4,862 $7.52 22,272 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Options Acquisiton 2019-11-22 9,076 $9.30 9,076 $9.30
Common Stock Common Stock Options Acquisiton 2019-11-22 4,862 $7.52 4,862 $7.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,881 2018-03-21 2027-03-20 No 4 M Direct
0 2017-03-18 2026-03-17 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.05, inclusive.
  2. Reflects Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 6,250 RSUs on March 21, 2020, and lapse as to 2,084 RSUs on November 13, 2020.
  3. The options granted became exercisable as follows: 1/3 on 3/21/2018 and the remaining 2/3 of such options became exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/21/2020.
  4. The options granted became exercisable as follows: 1/3 on 3/18/2017 and 2/3 of such options became exercisable over the following 24 months in equal amounts on a monthly basis.